Cross-Sector entity
Aerogel is most often covered alongside Anni Seaborne, which appears in 2 of these 2 stories. The clearest coverage concentration is consumer-trends: 1 of 2 stories, with the rest divided among 1 other category. The tracked stories average 2 original sources each.
2 verified stories tracked
Last mentioned: Aug 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Aerogel is most often covered alongside Anni Seaborne, which appears in 2 of these 2 stories. The clearest coverage concentration is consumer-trends: 1 of 2 stories, with the rest divided among 1 other category. The tracked stories average 2 original sources each. Aerogel appears in 2 tracked Cross-Sector stories from August 12, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Aerogel. Shared-story counts are live from our verified record — not editorial picks.
Ozen enters the sensitive-toothpaste category at a £10 premium price, armed with a novel aerogel formulation and the claimed first sensitivity patent in nearly 30 years. The launch targets a mass-market whitespace long dominated by weeks-long desensitizing formulations.
A 10-year development effort by NHS maxillofacial surgeon Dr Niall Kent produced Ozen, an aerogel-based toothpaste that seals dentinal channels and releases remineralizing ions — the first new sensitivity patent in nearly three decades. Claims of instant relief are winning endorsement from high-profile sports dentistry but remain unverified by published clinical trials.
Source: plymouthherald.co.uk · gazettelive.co.uk
